Optimizerx (OPRX) closed at $8.95 on November 11, 2026, down 4.3% from the previous close, on volume of 334,135 shares (30-day average 146,340).
Data as of November 11, 2026.
| # | Date | Strategy | Legs | Contracts |
|---|---|---|---|---|
| 1 | Oct 19, 2026 | Calendar Call Spread | 20-Nov : 18-Dec-26 7.5 C | 300 |
Ranked by contracts: multi-leg trades of 200 or more contracts on one day, through Nov 10, 2026. See the 10 largest for 30, 60 and 90 days
OptimizeRx Non-GAAP EPS of $0.20 beats by $0.04, revenue of $21.6M beats by $0.41M
Seeking Alpha News (Wed, 11-Nov 4:05 PM ET)
OptimizeRx Reports Third Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
Globe Newswire (Wed, 11-Nov 4:01 PM ET)
Here are the major earnings after the close Wednesday
Seeking Alpha News (Wed, 11-Nov 10:00 AM ET)
OptimizeRx Q3 2026 Earnings Preview
Seeking Alpha News (Tue, 10-Nov 5:35 PM ET)
These healthcare stocks have tumbled in 2026, yet Quant ratings stay positive
Seeking Alpha News (Tue, 10-Nov 12:38 PM ET)
OptimizeRx Sets Third Quarter 2026 Conference Call for November 11, 2026 at 4:30 p.m. ET
Globe Newswire (Wed, 28-Oct 7:30 AM ET)
OptimizeRx and PulsePoint Partner to Connect HCP Media Across the Funnel
Globe Newswire (Tue, 27-Oct 7:30 AM ET)
OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
Globe Newswire (Tue, 22-Sep 8:00 AM ET)
OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
Globe Newswire (Mon, 14-Sep 8:00 AM ET)
OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
Globe Newswire (Tue, 8-Sep 7:30 AM ET)
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
Optimizerx trades on the NASDAQ stock market under the symbol OPRX.
As of November 11, 2026, OPRX stock price declined to $8.95 with 334,135 million shares trading.
OPRX has a beta of 1.96, meaning it tends to be more sensitive to market movements. OPRX has a correlation of 0.13 to the broad based SPY ETF.
OPRX has a market cap of $165.49 million. This is considered a Micro Cap stock.
Last quarter Optimizerx reported $21 million in Revenue and $.16 earnings per share. This beat revenue expectation by $244,800 and exceeded earnings estimates by $.07.
In the last 3 years, OPRX traded as high as $22.25 and as low as $3.78.
The top ETF exchange traded funds that OPRX belongs to (by Net Assets): VTI, DFSV, VXF, IWC, ITOT.
OPRX has underperformed the market in the last year with a return of -45.8%, while SPY returned +12.6%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in OPRX shares. However, OPRX has outperformed the market in the last 3 month and 2 week periods, returning +30.5% and -1.2%, while SPY returned -1.5% and -1.3%, respectively. This indicates OPRX has been having a stronger performance recently.
OPRX support price is $8.97 and resistance is $9.74 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OPRX shares will trade within this expected range on the day.